Comparison of SYNTAX and Gensini Scores in the Decision of Surgery or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease.

coronary artery by-pass grafting gensini score multivessel coronary artery disease (mvcad) percutaneous coronary intervention revascularization decision syntax score

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2022
Historique:
accepted: 22 02 2022
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 30 3 2022
Statut: epublish

Résumé

 Many scoring systems have been developed to determine the extent of coronary artery disease (CAD) in patients with multi-vessel disease. The most widely used of these are Synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) and Gensini scoring. Gensini scoring system can successfully show coronary plaque burden. In our study, we aimed to test the predictive power of SYNTAX and Gensini scores for surgical or percutaneous intervention decisions made by the cardiac team in patients with three-vessel disease. A total of 476 patients without ST-elevation myocardial infarction with the three-vessel disease were included in the study. SYNTAX and Gensini scores of the patients were calculated from their coronary angiographies. Receiver operating characteristic curve (ROC-curve) analysis was performed using both scores.  Both the SYNTAX score and Gensini score were able to predict heart team decisions (AUC: 0.759, 0.680; p<0.001). Diabetes and smoking were more common in patients who were decided to have surgery (p<0.001).  In the light of our study results, the decisions to be made with the SYNTAX score will be closer to the decisions of the heart team than the Gensini score.

Identifiants

pubmed: 35345715
doi: 10.7759/cureus.22482
pmc: PMC8942066
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e22482

Informations de copyright

Copyright © 2022, Boyraz et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):126-30
pubmed: 22041042
EuroIntervention. 2009 May;5(1):50-6
pubmed: 19577983
J Nucl Cardiol. 2017 Jun;24(3):1046-1053
pubmed: 28224448
Medicine (Baltimore). 2021 Oct 15;100(41):e27331
pubmed: 34731103
Heart. 2014 Feb;100(4):276-87
pubmed: 23878176
Atherosclerosis. 2019 Aug;287:181-183
pubmed: 31104809
Clin Res Cardiol. 2013 Jul;102(7):495-503
pubmed: 23519584
Turk Kardiyol Dern Ars. 2018 Dec;46(8):683-691
pubmed: 30516526
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):50-8
pubmed: 19089938
Coron Artery Dis. 2019 Aug;30(5):367-376
pubmed: 30629001
Cureus. 2021 Oct 27;13(10):e19071
pubmed: 34824946
Front Cardiovasc Med. 2022 Jan 24;8:778615
pubmed: 35141291
Am J Cardiol. 2019 Mar 1;123(5):717-724
pubmed: 30558758
Curr Cardiol Rep. 2018 Mar 23;20(5):28
pubmed: 29572680

Auteurs

Bedrettin Boyraz (B)

Cardiology, Private Doruk Yildirim Hospital, Bursa, TUR.

Tezcan Peker (T)

Cardiology, Private Doruk Yildirim Hospital, Bursa, TUR.

Classifications MeSH